VIDGLIT (Teneligliptin (20mg))

Vidglit Tablet is indicated for the management of type 2 diabetes mellitus. This medication is intended to be used in conjunction with a balanced diet and consistent physical activity to help regulate blood glucose levels. Proper control is crucial for preventing major diabetic complications, such as damage to the kidneys and vision loss. Typically, Vidglit is recommended when dietary measures, physical activity, or other antidiabetic medications do not adequately manage blood sugar levels. It may be prescribed as a standalone treatment or alongside other diabetes medications based on individual health needs. Patients can take Vidglit with or without food, and the dosage will be tailored according to the specific condition and glucose levels of the individual. For optimal results, it is essential to take this medication at the same time every day and to continue its use unless directed otherwise by a healthcare professional. Adhering to the recommended diet and exercise plan is vital for effective diabetes management. The common side effects of this medication include low blood sugar, constipation, dizziness, headaches, and diarrhea. It is critical to identify the signs of hypoglycemia, such as feeling faint, excessive sweating, or dry mouth, and to be prepared to consume sugar or glucose candy should these occur. If any adverse effects persist or become concerning, it is important to contact a healthcare provider for guidance. Prior to initiating therapy with Vidglit, inform your healthcare provider of any history of kidney issues, cardiovascular diseases, or pancreatic disorders. Additionally, pregnant or nursing individuals should consult their doctor regarding the use of this medication. Regular monitoring, including assessments of kidney function and blood glucose levels, may be necessary to ensure the medication is effective.